Table 2 Postoperative Complications and Primary Systemic Treatment
Complication or Treatment | Group A | Group B | P-value |
|---|---|---|---|
(N = 170) | (N = 240) | ||
Complication | |||
Infection treated with antibiotics | 22 (12.9%) | 52 (21.7%) | 0.027 |
Thrombosis | 4 (2.4%) | 6 (2.5%) | 0.924 |
Lymph cysts | 4 (2.4%) | 50 (20.8%) | < 0.001 |
Intestinal fistula | 2 (1.2%) | 4 (1.7%) | 0.684 |
Repeat laparotomy for complications | 2 (1.2%) | 6 (2.5%) | 0.340 |
Postoperative bleeding | 0 (0) | 2 (0.8%) | 0.233 |
Primary systemic therapy | 0.100 | ||
Paclitaxel and platinum | 98 (57.6%) | 160 (66.7%) | |
Docetaxel and platinum | 68 (40%) | 76 (31.7%) | |
Other systemic treatment | 2 (1.2%) | 4 (1.7%) | |
No systemic treatment | 2 (1.2%) | 0 (0) | |